glp-1 roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist Enicepatide | CVRM | Genentech
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29


























